跳至主要内容
临床试验/NCT01961492
NCT01961492撤回不适用

Single Fecal Microbiota Transplantation Via Colonoscope as an Adjunct Therapy in the Treatment of Ulcerative Colitis

Turku University Hospital2 个研究点 分布在 1 个国家开始时间: 2013年10月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Activity of ulcerative colitis

研究概览

简要总结

The purpose of this study is to find out whether a single fecal microbiota transplantation is an effective and safe treatment as an adjunct to standard therapy in patients with ulcerative colitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Year 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • active ulcerative colitis (PUCAI 10-64) in whom fecal microbiota transplantation via colonoscope can be performed

排除标准

  • severe ulcerative colitis (PUCAI > 65)

研究组 & 干预措施

Fecal microbiota transplantation

Active Comparator

A single fecal microbiota transplantation via colonoscope as an adjunct therapy to standard medical treatment

干预措施: Fecal microbiota transplantation (Other)

Standard medical treatment

No Intervention

Standard medical treatment as recommended by the ECCO Guidelines of UC therapy.

结局指标

主要结局

Activity of ulcerative colitis

时间窗: Within 1 year after the intervention

Change from baseline in the Pediatric Ulcerative Colitis Activity Index (PUCAI) at 1 month, 3 months, 6 months, and 12 months.

次要结局

  • Adverse events(Within 1 year after the intervention)
  • Colonic inflammation(Within 1 year after the intervention)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Marko Kalliomäki

Specialist

Turku University Hospital

研究点 (2)

Loading locations...

相似试验

Fecal Microbiota Transplantation in Patients With... | 临床试验